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Abstract
Vaccination can delay the peak of a pandemic influenza wave by reducing the number of individuals initially susceptible to
influenza infection. Emerging evidence indicates that susceptibility to severe secondary bacterial infections following a
primary influenza infection may vary seasonally, with peak susceptibility occurring in winter. Taken together, these two
observations suggest that vaccinating to prevent a fall pandemic wave might delay it long enough to inadvertently increase
influenza infections in winter, when primary influenza infection is more likely to cause severe outcomes. This could
potentially cause a net increase in severe outcomes. Most pandemic models implicitly assume that the probability of severe
outcomes does not vary seasonally and hence cannot capture this effect. Here we show that the probability of intensive
care unit (ICU) admission per influenza infection in the 2009 H1N1 pandemic followed a seasonal pattern. We combine this
with an influenza transmission model to investigate conditions under which a vaccination program could inadvertently shift
influenza susceptibility to months where the risk of ICU admission due to influenza is higher. We find that vaccination in
advance of a fall pandemic wave can actually increase the number of ICU admissions in situations where antigenic drift is
sufficiently rapid or where importation of a cross-reactive strain is possible. Moreover, this effect is stronger for vaccination
programs that prevent more primary influenza infections. Sensitivity analysis indicates several mechanisms that may cause
this effect. We also find that the predicted number of ICU admissions changes dramatically depending on whether the
probability of ICU admission varies seasonally, or whether it is held constant. These results suggest that pandemic planning
should explore the potential interactions between seasonally varying susceptibility to severe influenza outcomes and the
timing of vaccine-altered pandemic influenza waves.
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Introduction
Both seasonal and pandemic influenza are associated with a
considerable burden of disease, in the form of absenteeism,
hospitalizations, intensive care unit (ICU) admissions, and deaths
[1]. Severe complications can occur even in patients without
chronic health conditions [2]. Complications are often the result of
secondary bacterial infections, and the delay between primary
influenza and the diagnosis of subsequent bacterial infections
means that the primary influenza infection is not always confirmed
[3]. Data from the influenza pandemics of 1918, 1957 and 1968
are consistent with secondary bacterial pneumonia causing the
majority of influenza-associated deaths [4]. Pandemic influenza
can be associated with a higher burden of disease than seasonal
influenza, if only because more individuals become infected during
a pandemic due to lower levels of natural immunity in the
population, as compared to typical seasonal influenza [5].
As with previous influenza pandemics, the 2009 H1N1
pandemic imposed a significant disease burden [6]. Pulmonary
complications were common, with primary influenzal pneumonia
and acute respiratory distress syndrome in adults and secondary
bacterial pneumonia in children [7]. Secondary pneumococcal
infections were often a factor in severe and fatal cases of influenza
[8]. However, unlike in previous pandemics, immunization
programs may have played a mitigating role, despite late
introduction of the vaccine. The use of a vaccine against pandemic
influenza for the first time ever suggests that immunization will
form a part of mitigation plans for future influenza pandemics.
However, as always, it remains necessary to address how best to
design and execute large-scale immunization programs in the face
of uncertainties.
Seasonal influenza is characterized by strong seasonal variation
in incidence, generally surging in the winter months in temperate
regions [1]. Severe outcomes such as influenza-related hospital-
izations and deaths also peak in winter [9,10]. In comparison,
although influenza pandemics may be influenced by seasonality,
they do not always follow the same pattern: spring, fall and winter
waves have all occurred in past pandemics [11]. One possible
explanation for this difference is that the widespread host
susceptibility that accompanies an antigenically novel strain means
an outbreak can occur even when seasonal factors do not support
its transmission.
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Suggested contributors include seasonal variation in host health,
school attendance, ambient temperature, indoor/outdoor absolute
humidity, and ultraviolet (UV) radiation intensity [12–15]. Some
of these observations have led to a hypothesis that innate host
susceptibility varies seasonally, enabling seasonal outbreaks to
occur. Impairments of the antimicrobial peptide (AMPs) systems
that respond to influenza infection are caused by very low levels of
25-hydroxy-vitamin D [25(OH)D] in the winter months [16].
Vitamin D levels vary with seasonal trends in UV radiation levels
and are therefore highest in August and lowest in February (since
most Vitamin D is obtained through sun exposure, not diet). This
implies heightened host susceptibility in late fall, winter, and early
spring [17].
Susceptibility to secondary bacterial infections from influenza
also varies seasonally, and exposure to UV-B radiation is known to
reduce the risk of invasive pneumococcal disease (pneumonia,
bacteremia, and meningitis) [18]. Seasonality in susceptibility to
secondary bacterial infections suggests that influenza outcomes
might be more severe when peak influenza incidence aligns with
peak susceptibility to secondary bacterial infections. Immunization
alters the susceptibility of the host population to influenza infection
and may thereby affect the timing of pandemic influenza peaks
[19]. Therefore, a pandemic immunization program may mitigate
a fall wave and reduce the total number of influenza infections.
However, at the same time, it may push some influenza incidence
into winter months where an influenza infection is more likely to
cause severe secondary bacterial infections. Because of these two
factors have competing effects on the number of severe outcomes,
it is not clear a priori what their net impact will be. Thus, it is
worthwhile to investigate the potential for such a result.
Mathematical models can be used to address such questions
because they offer an opportunity to explore a wide range of
scenarios, including not only scenarios close to what actually
happened but also scenarios that might have happened, or that
may happen in the future. A significant amount of modeling has
addressed the topic of mitigation strategies for influenza
pandemics [20–30]. Some of this work investigates the potential
role of interventions or co-infections in creating multiple pandemic
waves [23–25,29]. Many models only track a single outcome
measure–the incidence of influenza infection–and hence cannot
predict serious outcomes like hospitalizations and ICU admissions.
However, severe outcomes from influenza are very important for
decision-making given that most individuals recover from infection
without experiencing severe outcomes. Several models do include
such outcomes, but they tend to assume the probability of severe
outcomes per influenza infection does not vary seasonally [20,27]
and hence they cannot be used to explore interactions between
vaccine-altered timing of pandemic influenza waves and seasonal
variation in susceptibility to severe outcomes such as caused by
secondary bacterial infections.
Here, we use a mathematical model to investigate conditions
under which a pandemic immunization program could increase
the number of ICU admissions by increasing influenza infections
in months where infection is more likely to lead to ICU admission.
The model assumes seasonality in both influenza transmission
rates and susceptibility to influenza infection, as well as seasonality
in host susceptibility to ICU admission caused by influenza. The
probability that an influenza infection leads to an ICU admission,
as a function of time of year, is estimated using data from the 2009
H1N1 influenza pandemic. We also compare the predicted
number of ICU admissions when the probability of ICU admission
per incident influenza infection varies seasonally to when it does
not. The latter simplifying assumption is implicit to most pandemic
models, hence this comparison allows us to determine its impact
on model predictions.
Methods
Our SIRS (Susceptible-Infectious-Recovered-Susceptible) com-
partmental model of influenza transmission divides the population
into Susceptible, Infectious and Recovered/Immune categories
(see Text S1). Despite its simplifying assumptions, the SIRS model
and its variants have been shown to capture features of real
influenza outbreaks, such as observed epidemic curves and
seasonal patterns [23,25,31,32]. Susceptible individuals become
infectious at a rate equaling an infection rate parameter b times
the number of susceptible individuals (S) times the proportion of
the population that is infectious (I=N). The infection rate b varies
seasonally to reflect seasonal variation in both influenza transmis-
sibility and susceptibility to influenza infection [33,34]. The
amplitude of seasonality is controlled by k1 (amplitude of
seasonality in transmission due to changes in school attendance
over the school year) and b1 (amplitude due to any other sources of
seasonality in transmission and susceptibility to infection).
Individuals flow from infectious (I) to immune (R) at a rate c
(where 1=c is the mean infectious period). The average value of b
over a year, SbT, can be determined from the basic reproduction
number R0 according to SbT&cR0 (see Text S1). Individuals are
immunized at a rate r and the vaccine has efficacy e. Efficaciously
vaccinated individuals are moved from the S to the R
compartment. Individuals are born into the susceptible compart-
ment at rate m per capita, and individuals in any compartment die
from all causes at rate n per capita. The strain is introduced at time
tentry during the summer, and a proportion R(0) of individuals are
assumed initially immune due to previous vaccination and
infection (e.g. Spring wave).
As in many previous models, we model antigenic drift as a flow
of individuals from immune (R) to susceptible (S) due to waning
immunity at a rate v (where 1=v is the average duration of
immunity). This gradual loss of immunity represents the effects of
antigenic drift within a population. However, new cross-reactive
antigenic variants can also be introduced to a population by case
importation, meaning a large proportion of the population must
be immediately re-classified as susceptible. This may happen
within a pandemic year: for instance, sequential variants of the
virus have been posited as one possible reason for the repeated
waves such as observed in the 1918 pandemic [25,35]. Hence at
the end of December (during the holiday travel period), a
proportion y of recovered individuals were transferred to the
susceptible compartment to represent importation of a novel cross-
reactive strain into the population. (We also explored y~0 in
sensitivity analysis.) We note that modelling the effects of
importing a cross-reactive strain would not be captured adequately
through the y parameter if co-circulation of the two strains were
occurring; however, in our simulations, the fall wave caused by a
first strain is over by the time the cross-reactive strain is introduced
and hence this is not an issue. Parameter values and their sources
appear in Table S1 [36–45]. The model was simulated in Matlab
[46].
The number of new ICU admissions per week (O) was taken as
O~sx, where x is number of incident influenza cases per week
(derived from the SIRS model) and s~s(t) is the probability that
an influenza infection in week t causes ICU admission. The
function s(t) varied seasonally according to a modified sinusoidal
function (Table S2). This function was fitted to data on lab-
confirmed influenza cases and ICU admissions attributable to
influenza infection from the 2009 H1N1 pandemic [47–49].
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how model dynamics vary across a range of plausible parameter
values, we conducted a probabilistic (Monte Carlo) sensitivity
analysis. To ensure model realism, the sensitivity analysis also
excluded parameter combinations that gave rise to unrealistic
dynamics,. We defined lower and upper plausible ranges for the
parameters c, v, b1, k1, y, R0, tentry and the initial condition R(0)
(Table S1). We conducted many realizations, and for each
realization we drew samples from these ranges for each parameter,
simulated the model equations, and generated outcomes for each
sampled set of parameter values. However, to ensure realism and
consistency with experience from past pandemics, we excluded
any realizations (1) that yielded a summer peak in the following
calendar year, (2) that did not end up producing normal seasonal
influenza peaks (i.e. a single peak in fall, winter or spring) in any of
the three following calendar years, or (3) that produced closely
spaced peaks in both December and February of the pandemic
year (these simulations were excluded because we wished to
simplify the analysis by restricting attention to simulations where
there was only one peak per season). These three criteria were
applied in the absence of an immunization program. Fall was
defined as September to November, winter as December to
February, and spring as March to May.
Approximately 1,000 simulations survived this filtering Monte
Carlo algorithm and were used to generate results for the
prevalence and incidence of influenza infection as well as the
incidence of ICU admissions, in the absence of an immunization
program. From this, we computed the total number of ICU
admissions from the fall to the following summer. To evaluate the
impact of vaccination, we ran the same set of simulations in the
presence of an immunization program. We analyzed a total of 30
immunization program designs based on a subset of the following
combinations of characteristics: (1) Starting September 1, October
1, or November 1, (2) lasting 1, 2, 3, 4, 5 or 6 months, (3)
vaccinating 10%, 20%, 40% or 60% of the population (Table S3).
However we only report results for seven profiles denoted ‘A’
through ‘G’ vaccinating 40% of the population (Table 1) since the
other 23 profiles either produced qualitatively similar results or
produced trivial results because most vaccine ended up being
administered after the fall wave.
Results
The best fit of the seasonally-varying probability of ICU
admission per influenza infection to the data appears in Figure 1.
This figure shows a clear increase in the probability of ICU
admission per new influenza infection as winter progresses, even as
the total number of influenza infections declines as the fall wave
ends. The probability of being admitted to ICU due to an
influenza infection in the extrapolated model is highest in the
months of January and February, which is consistent with what we
would expect based on the literature describing peak susceptibility
to secondary bacterial infections in these months. Only data to
mid-December were used to fit the model because influenza-
attributable ICU admissions and lab-confirmed influenza cases
became too few after that point to support fitting. Also, numbers
reported after late December had new counts based on
retrospective analysis of the spring and fall waves rather than
being based on new case reports alone, which could have
confounded the results.
Figure 2 shows how influenza incidence, number of ICU
admissions, and susceptibility to influenza infection evolve over
time for a typical realization of the simulation, with and without a
vaccination program. Without a vaccination program, there is a
single peak in infection prevalence in October, which also
corresponds to a peak in the number of ICU admissions
(Figure 2a). The pool of susceptible individuals is rapidly depleted
by the first wave, but in December it begins increasing again due
to the effects of case importation, and thereafter climbs gradually
due to recruitment of new susceptible individuals through births
and antigenic drift (Figure 2b). This increase in susceptibility is not
sufficient to cause a second wave, although it does cause a second
peak in the number of ICU admissions (Figure 2a). The addition of
a vaccination program (profile C from Table 1) in this example
alters these dynamics considerably. Immunization significantly
reduces the number of individuals infected by the first pandemic
wave, which still peaks in October, but at a considerably lower
level (Figure 2c versus Figure 2a). This reduces the number of ICU
admissions in October (Figure 2c). However, due to the mitigating
effects of the vaccination program, the pool of susceptible
individuals is larger by the start of the following January
(Figure 2d versus Figure 2b). As a result, there is a second
pandemic wave in January when the probability of severe
outcomes is highest, which causes a large peak in ICU admissions
(Figure 2c). The net result is that the total number of ICU
admissions from Fall to Summer is higher with the vaccination
program than without it. In this simulation, the combination of
higher susceptibility due to importation of a cross-reactive strain
December and implementation of an immunization program in
early Fall are enough to increase total susceptibility in January to
the point where a second wave is possible.
Under certain vaccination programs, an increase in net ICU
admissions can occur. For example, we found that vaccination
profile C leads to an increase in ICU admissions in 18% of the
approximately 1,000 realizations used for the analysis (Figure 3).
This is more than any other vaccination profile, and–surprisingly–
despite the fact that profile C also averts more influenza infections
than any other profile. Profile C, which covers 40% of the
population in September, vaccinates more individuals prior to the
Fall wave than do Profiles A, B or D, in which vaccination also
starts in September but is spread over two or three months and
continues during the Fall wave. Similarly, profiles A, B and D
Table 1. Description of different vaccination profiles.
*
Vaccination Profile: A B C D E F G
Month of initiation Sep Sep Sep Sep Oct Oct Oct
Length of vaccination program (months) 3 2 1 3 3 2 1
Distribution per month 1/3, 1/3, 1/3 1/2, 1/2 1 1/2, 1/4, 1/4 1/3, 1/3, 1/3 1/2, 1/2 1
*A 40% vaccination rate was assumed for results presented in main text. The distribution per month indicates what portion of the 40% were vaccinated each month. So,
in vaccination profile D, in September, half of the targeted population gets immunized with a fourth of the targeted population getting immunized in each of the
following 2 months.
doi:10.1371/journal.pone.0023580.t001
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respectively. In comparison, profiles E–F which start immunizing
in October always avert influenza infections without causing a net
increase in ICU admissions (Figure 3). This occurs because in most
realizations, the fall wave is already under way when vaccination
starts in October. Hence, profiles E–F prevent fewer influenza
infections and consequently shift fewer susceptible individuals to
the winter months when the risk of severe outcomes from influenza
infection is higher.
In our baseline parameters, the value of v (within-population
antigenic drift) was too small to cause an increase in susceptibility
that, when combined with the mitigating effects of a vaccine,
would increase ICU admissions. However, if v is increased
sufficiently (1=v[(2,6) months), similar effects are observed as for
large values of y, and an immunization program can increase the
total number of ICU admissions even if y~0 (Figure S1). Hence,
a vaccination program can cause adverse outcomes whether
susceptibility increases suddenly due importation of a cross-
reactive strain, or gradually due to within-population antigenic
drift. In the special case y~0 (no importation of cross-reactive
strain) and v is at its smaller baseline value, no realizations yielded
an increase in the number of ICU admissions for any of the
vaccination profiles (Figure S2). In the case 1=v[(2,6) months
(rapid antigenic drift), and yw0, we again found that some
vaccination programs (especially profile C) could lead to more
ICU admissions (Figure S3). Hence, our model predicts an
Figure 1. Probability of ICU admission per influenza infection, estimated from the H1N1 pandemic of 2009. Data from the H1N1
pandemic of 2009 (black line) was fit to our seasonally varying function (Table S2) and extrapolated (solid grey line). Weekly H1N1 positive specimens
(dashed grey line) is on the secondary vertical axis.
doi:10.1371/journal.pone.0023580.g001
Figure 2. Example where vaccination increases the number of ICU admissions. A typical run where the number of ICU admissions increased
due to vaccination for Profile C for 40% vaccination rate. (a), infected incidence (black) and number of ICU admissions (grey) over time without
vaccination (top panel) and (c), with vaccination (bottom panel). (b), time series of the number of susceptible individuals without (top panel) and (d),
with vaccination (bottom panel). Vaccination leads to an increase in the number of ICU admissions by increasing the number of susceptibles available
for another wave leading to higher incidence and higher morbidity. Parameter values: L~2:5977 years, D~0:0192 years, b1~0:0609, k1~0:0708,
R0~2:0627, tentry~240, y~0:3325, R(0)~2927100 and r~0:4.
doi:10.1371/journal.pone.0023580.g002
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cross-reactive strain occurs or if antigenic drift within the
population is sufficiently fast.
To understand which parameter combinations are most likely to
increase the number of ICU admissions, we compared scatter plots
of realizations where vaccination led to more ICU admissions to
scatter plots of realizations where it led to fewer ICU admissions,
using vaccination profile B as an example (Figure 4). These scatter
plots suggest that vaccination is more likely to cause an increase in
ICU admissions when the duration of infectiousness is longer
(smaller c), antigenic drift is more rapid (larger y), or when the
entry time is later in the summer (larger tentry). For a given R0,a
longer duration of infectiousness will spread out the epidemic
curve, increasing incidence in the winter months and hence ICU
admissions. A later entry time or more antigenic drift before
January likewise mean that susceptibility, and hence incidence, is
higher in the winter months. Thus, in general, when processes that
tend to shift susceptibility to winter months are already present,
implementation of a vaccination program is more likely to cause a
further increase in susceptibility in winter and hence a net increase
in ICU admissions. As the duration of the immunization program
decreases from 3 months (Profile A) to 1 month (Profile C), the
range of values for c, y and tentry for which vaccination caused
more ICU admissions become widened (results for Profiles A and
C not shown).
For profiles A–D, vaccination increases the number of ICU
admissions every time there is a transition from a fall wave without
vaccination, to fall and winter waves with vaccination (Table 2). In
this case, the vaccination program creates a small second wave at a
time where the risk of ICU admission is higher. This also happens
very frequently when vaccination causes a transition from a fall-
and-spring wave to a fall-and-winter wave, or from a fall wave to a
fall-and-spring wave (Table 2). In this case, vaccination adds
susceptibility before the start of the winter and thus leads to an
earlier second wave (in winter instead of spring), which thereby
results in more ICU admissions. Hence, ICU admissions are most
likely to increase if vaccination increases susceptibility enough to
cause a second wave in the winter months. These are often the
outliers in Figure 3.
It is instructive to compare the predicted number of severe
outcomes in a model with seasonally varying susceptibility to
severe outcomes (‘‘seasonal estimator’’) to a model where
susceptibility to severe outcomes is the same in all months
(‘‘average estimator’’). If the predictions are significantly different,
this provides a rationale for pandemic influenza models to include
interactions between seasonally varying susceptibility to severe
outcomes and timing of vaccine-altered influenza pandemic waves.
We made this comparison by replacing the seasonally varying
probability of ICU admission per influenza infection with a
constant probability, parameterized using the same data from the
2009 H1N1 pandemic (see Text S1). Across all vaccine program
profiles, the model predictions vary significantly depending on
whether the average or seasonal estimator is used (Table 3). The
average estimator predicts somewhat more ICU admissions than
the seasonal estimator, in the absence of a vaccination program.
This occurs because the probability of ICU admission per
influenza infection in the fall months (when a pandemic peak
occurs) according to the seasonal estimator is lower than the
probability used in the average estimator, which was obtained by
averaging the frequency of ICU admissions over the period of the
whole pandemic including later months when ICU admission was
a more likely outcome of infection. However, the seasonal
estimator predicts more ICU admissions averted by vaccination
programs (Table 3). Also, the variation in ICU admissions averted
by vaccination is much higher across the different vaccination
profiles for the seasonal estimator than for the average estimator.
For example, more ICU admissions are averted under the seasonal
estimator than the average estimator for profile A, but the
difference is quite low for profile C. Results are similar for 10%,
20% and vaccine 60% coverage (results not shown). For the case of
a pathogen that is more virulent than the 2009 H1N1 pandemic
strain was, leading to a uniformly higher probability of ICU
Figure 3. ICU admissions averted (top) and infections averted (bottom) for different vaccination profiles. Boxplots of ICU admissions
and infections averted with different vaccination profiles for 40% vaccination rate. Vaccinating a larger proportion of the population in advance can
lead leads to a lower number of infections in total but a higher number of ICU admissions. Points are drawn as outliers (z) if they are larger than
q3z1:5(q3{q1) or smaller than q1{1:5(q3{q1), where q1 and q3 are the 25th and 75th percentiles, respectively.
doi:10.1371/journal.pone.0023580.g003
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the seasonal estimator predicts a higher number of ICU
admissions averted by vaccination programs (results not shown).
We carried out a similar comparison of average and seasonal
estimators for the case where y~0, corresponding to no
importation of a cross-reactive strain in December (Table S4).
We found that, as for the yw0 case, both the predicted number of
ICU admissions with vaccination, and the number of ICU
admissions averted by a vaccination program, differed widely
depending on whether the average or seasonal estimator is used.
Hence, even when vaccination cannot cause an increase in ICU
admissions by increasing incidence in winter months, the predicted
number of ICU admissions averted by vaccination programs can
vary considerably depending on whether or not seasonality in the
probability of severe outcomes is taken into account.
Discussion
Here we used a model to explore potential interactions between
seasonally varying susceptibility to severe outcomes from influenza
infection and the timing of influenza pandemic waves as modified
by vaccination programs. We found that vaccination programs
could increase ICU admissions by increasing susceptibility to
infection in winter months if (1) there is a pre-existing tendency
Figure 4. Scatter plots of realizations where ICU admissions increased or decreased due to vaccination, as a function of various
parameters. Parameters where vaccination caused a higher (black circles) or lower (blue diamonds) number of ICU cases for Profile B for 40%
vaccination rate. There is some evidence for clustering near the upper constraint for the entry time parameter. R0 (horizontal axis in all panels) values
smaller than approximately 1.7 did not give rise to simulations that passed our filtering criterion, hence the lack of data for these values of R0. Longer
duration of infectiousness (smaller c), more rapid antigenic drift (larger y), or when the entry time is later in the summer (larger tentry) seem more
conducive to resulting in an increase in the number of ICU admissions.
doi:10.1371/journal.pone.0023580.g004
Table 2. Number of realizations where vaccination led to a
higher number of ICU cases because of a transition of
pandemic waves.
*
Vaccination Profile A B C D
Fall-and-spring to fall-and-winter 0 (0) 0 (0) 18 (18) 0 (0)
Fall to fall-and-winter 0 (0) 1 (1) 6 (6) 1 (1)
Fall to fall-and-spring 0 (0) 4 (5) 14 (14) 2 (4)
Fall to fall-and-summer 0 (0) 2 (3) 12 (22) 1 (1)
*The values in parenthesis are the total number of results observed out of 1000
included simulations for the specific vaccination profile for 40% vaccination
rate.
doi:10.1371/journal.pone.0023580.t002
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importation of a cross-reactive strain, and (2) vaccination occurs in
advance of the fall pandemic wave. We found that scenarios where
vaccination began during the pandemic wave instead of before it
did not increase ICU admissions, simply because these programs
do not protect as many individuals by virtue of starting later, and
hence they do not increase susceptibility enough in the winter. An
increase in ICU admissions occurred only when we allowed for
introduction of a cross-reactive variant in December or when
antigenic drift was sufficiently fast. However, even when we did
not allow this to happen, the predicted number of ICU admissions
averted by vaccination varied significantly depending on whether
we allowed the probability of ICU admission per influenza
infection to vary seasonally or whether we force it to be constant,
suggested the current approach of assuming the same probability
of severe outcomes across all months may be too limited.
These results suggest that fall pandemic waves may be a blessing
in disguise in some respects, since under a fall wave, the majority
of individuals are infected and attain natural immunity before the
time of year when the risk of severe outcomes from influenza
infection is highest. However, the number of severe outcomes due
to a fall pandemic wave are not necessarily small in absolute terms.
For example, the Fall wave of the 1918 pandemic was the deadliest
on historical record, and the cause of this may have been
secondary bacterial infections [4]. Baseline host susceptibility to
severe secondary bacterial infections has likely evolved over the
past century.
Here we focused on ICU admissions as a marker of severe
outcome measures. Although risk of ICU admission is likely to
correlate with risk of death and risk of hospitalization, an
expanded model including a broader array of outcomes may
yield different predictions. Our discussion about the causes of
higher severity in winter months focused on secondary bacterial
infections, but there are other reasons why health outcomes of
influenza may be worse in the winter months such as greater
crowding of ICUs and demand for resources such as extra-
corporeal membrane oxygenation (ECMO) due to seasonal peaks
in non-influenzal pneumonia and other seasonal viral infections.
We used a simplified method of capturing the effects of
importing a cross-reactive strain by changing the number of
susceptible individuals in December, rather than explicitly
modelling two strains. The results of a two-strain model can differ
significantly, especially if both strains are co-circulating or differ in
their antiviral resistance. However, in our case this will have little
effect since the first pandemic wave was finished by early
December in most realizations and hence co-circulation would
not occur. The degree of natural cross-protection is reflected in
how many individuals are moved to the susceptible compartment.
Therefore, the impact of this simplified approach is minimal.
Previous work on the impact of pandemic interventions on the
susceptibility profile of a population over time has identified
conditions where early application of an intervention (in
particular, antiviral drugs) can lead to a second wave by boosting
susceptibility in later months [23]. This previous work did not
include severe outcomes as a model output. However, their
findings combined with ours do suggest that widespread
prophylactic use of antiviral drugs in fall or early winter might
have a similar effect of increasing the total number of ICU
admissions. In fact, we expect the effect to be greater because
antiviral drugs only reduce susceptibility while they are being
taken, whereas vaccines confer longer term protection.
Here, we relied on data from the 2009 H1N1 pandemic. The
2009 pandemic did not have a 2010 winter or spring wave in
northern countries so we extrapolated the fall data to obtain the
probability of ICU admission in winter and spring. However, we
expect many of our results to generalize for any pandemic in
which the probability of severe outcomes per influenza infection
varies seasonally. It is also important to note that there is potential
for confounding in the model estimates for case severity since other
factors in additional to seasonal variation in severity may influence
the probability of severe complications. For instance, large
subpopulations may have co-morbidities that predispose them to
severe outcomes, and these subpopulations may experience the
highest incidence of influenza infection at a time of year that is
different from that of the rest of the population [50]. Despite this,
our model fits showed that there is not much change in the
probability of a severe outcome in the summer when the disruptive
effects of this kind of confounding variable would be strongest,
which agrees well with what was observed in the first wave of the
pandemic of 2009 [51].
Including other features of influenza transmission might change
our quantitative predictions. For instance, explicitly modelling co-
circulation of a second drug-resistant strain, modelling the
circulation of relevant bacterial infections, or adding age structure,
social structure, or other heterogeneities could influence model
predictions. The predictions of a model with feedback between
bacterial transmission and influenza transmission (where each
influences the other) in particular might diverge considerably from
our model predictions. However, most of these potential
extensions should not change the fact that vaccination can delay
the peak of an epidemic and thus increase influenza incidence in
winter months, and that this might increase the number of ICU
Table 3. Comparison between ICU estimates (standard deviations) from the average and seasonal estimators.
*
Vaccination Profile (?)A B C D E F G
Number of ICU admissions on average
using the average function without vaccination
4391 (756) 4391 (755) 4392 (756) 4392 (755) 4388 (755) 4389 (754) 4392 (756)
Number of ICU admissions on average using
the seasonal function without vaccination
3443 (2882) 3439 (2871) 3438 (2864) 3443 (2882) 3431 (2877) 3436 (2876) 3447 (2883)
Number of ICU admissions averted on
average using the average function
341 (255) 378 (278) 448 (321) 373 (265) 329 (280) 270 (259) 277 (268)
Number of ICU admissions averted on
average using the seasonal function
1192 (1662) 1081 (1740) 538 (2309) 1084 (1703) 1454 (1863) 1334 (1700) 1359 (1752)
*For simulations of approximately 1000 runs each for the two strain case for 40% vaccination rate. The mean of the number of ICU admissions on average using both
the average and seasonal function vary a little bit across vaccination profiles due to runs (from particular combinations of parameters) resulting in a flag that made our
pandemic filtering criteria exclude it.
doi:10.1371/journal.pone.0023580.t003
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that seasonal estimators and average estimators give rise to very
different predicted ICU admissions will be robust under potential
model extensions.
Effective pandemic planning requires accounting for various
possible scenarios that may unfold in a real pandemic. Use of a
vaccine in future pandemics is a likely scenario, given its
prominent role in the 2009 H1N1 pandemic. Future increases in
manufacturing efficiency could also mean pandemic vaccines are
available well in advance of future fall pandemic waves. Our
research has shown that the predicted impact of vaccine programs
on the incidence of severe outcomes due to influenza infection can
be different–sometimes even opposite–to the impact on total
influenza infections, if susceptibility to severe outcomes is modelled
as a seasonally varying function. More research is required to
understand how including interactions between seasonal suscep-
tibility to severe outcomes and vaccine-altered pandemic waves in
models can change which vaccine programs are predicted to be
optimal from the public health perspective. Future models should
include the kinds of severe outcomes that are often at the front of
policy-makers’ minds, such as physician office visits, hospitaliza-
tions and ICU admissions, and they should also explore whether
their conclusions change if the probability of severe outcomes is
allowed to vary seasonally.
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